Landscape Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History
Bought
Maintained
Sold
Other funds holding COEPW
RCM
MC
SIA
TSS
HHGC
CS
Landscape Capital Management's COEPW Position: Q1 2026 in Review
Landscape Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2026, closing a stake of 32,045 shares — an estimated $346 sold.
Landscape Capital Management first reported a position in COEPW in Q2 2022 and held it in 15 quarters. The position peaked at $4.72K in Q1 2023. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.
- Landscape Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q1 2026 after selling out during the quarter.
- Landscape Capital Management sold 32,045 Coeptis Therapeutics Warrants shares in Q1 2026, an estimated $346.
- Landscape Capital Management first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 15 quarters.
- Landscape Capital Management's Coeptis Therapeutics Warrants position peaked at $4.72K in Q1 2023.
- 10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.
Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.